title: [Human African trypanosomiasis in Côte d'Ivoire and Burkina Faso: optimization of epidemiologic surveillance strategies].
abstract: The objective of this paper was to describe recent data from Burkina Faso and Côte d'Ivoire on Human African Trypanosomosis medical monitoring in order to (i) update the disease situation in these two countries that have been sharing important migratory, economic and epidemiological links for more than a century and (ii) to define the future strategic plans to achieve the goal of a sustainable control/elimination process. Results of active and passive surveillance indicate that all sleeping sickness patients diagnosed these last years in Burkina Faso were imported cases from Côte d'Ivoire. Nevertheless the re-introduction of the parasite is effective and the risk of a resumption of transmission exists. In Côte d'Ivoire, few cases are still diagnosed in several historical foci and the fear exists that the disease could reemerge in these foci or spread to other areas. In order to achieve a sustainable elimination of sleeping sickness in these two countries, control entities have to adapt their strategy to the different epidemiological contexts. At the exception of specific cases, the current disease prevalence no longer justifies the use of expensive medical surveys by exhaustive screening of the population. New disease control strategies, based on the exchange of epidemiological information between the two countries and integrated to the regular national health systems are required to target priority intervention areas. Follow-up in time of both treated patients and serological suspects that are potential asymptomatic carriers of parasite is also important. In parallel, researchers need to better characterize the respective roles of the human and animal reservoir in the maintenance of transmission and evaluate the different control strategies taken by National Control Programs in term of cost/effectiveness to help optimize them.
authors.affiliation: Programme National de Lutte contre la Trypanosomiase Humaine Africaine (PNLTHA) au Burkina-Faso, Ouagadougou, Burkina Faso.
authors.forename: R
authors.initials: R
authors.lastname: Kambiré
authors.forename: K
authors.initials: K
authors.lastname: Lingué
authors.forename: F
authors.initials: F
authors.lastname: Courtin
authors.forename: I
authors.initials: I
authors.lastname: Sidibé
authors.forename: D
authors.initials: D
authors.lastname: Kiendrébéogo
authors.forename: K E
authors.initials: KE
authors.lastname: N'gouan
authors.forename: L
authors.initials: L
authors.lastname: Blé
authors.forename: D
authors.initials: D
authors.lastname: Kaba
authors.forename: M
authors.initials: M
authors.lastname: Koffi
authors.forename: P
authors.initials: P
authors.lastname: Solano
authors.forename: B
authors.initials: B
authors.lastname: Bucheton
authors.forename: V
authors.initials: V
authors.lastname: Jamonneau
mesh_terms: D000293:Adolescent; D000328:Adult; D002050:Burkina Faso / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D007560:Cote d'Ivoire / Q000453:epidemiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011159:Population Surveillance / Q000379:methods; D015995:Prevalence; D014353:Trypanosomiasis, African / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D055815:Young Adult